Patent ID: 11952423
Assignee: DAIICHI SANKYO COMPANY, LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 7:
8. The molecule according to claim 7, wherein the antibody or the binding fragment thereof that binds specifically to CD3 comprises:
(CCH1) a heavy chain CDRH1 consisting of the amino acid sequence of SEQ ID NO: 141;
(CCH2) a heavy chain CDRH2 consisting of the amino acid sequence of SEQ ID NO: 142 or an amino acid sequence derived from the amino acid sequence of SEQ ID NO: 142 in which amino acid 3 is N or S;
(CCH3) a heavy chain CDRH3 consisting of the amino acid sequence of SEQ ID NO: 143;
(CCL1) a light chain CDRL1 consisting of the amino acid sequence of SEQ ID NO: 144;
(CCL2) a light chain CDRL2 consisting of the amino acid sequence RDD or an amino acid sequence derived from the amino acid sequence RDD in which amino acid 2 is N; and
(CCL3) a light chain CDRL3 consisting of the amino acid sequence of SEQ ID NO: 146.